相关实验视频
Updated: May 9, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.3K
药品供应链的多道定价策略,考虑道力量和价格竞争
PloS one
|May 2, 2025
概括
在线和实体零售道之间的药品供应链竞争可以提高药品价格. 直接销售道和更高的医疗保险退款率可以降低价格并提高利.
科学领域:
- 供应链管理 供应链管理
- 制药经济学 制药经济学
- 游戏理论 游戏理论
背景情况:
- 制药制造商和零售商越来越多地采用在线销售道.
- 多道策略在定价和利分配方面引入了复杂的动态.
研究的目的:
- 分析多道竞争对药品定价和供应链利的影响.
- 评估道力量和医疗保险政策对制药市场的影响.
主要方法:
- 为制药供应链开发三种游戏理论模型.
- 分析实体零售,在线零售和直销道之间的价格竞争.
- 包括诸如频道功率和医疗保险退款率等因素.
主要成果:
- 道间的价格竞争不会持续降低药品价格;实体和在线道之间的竞争可能会增加价格.
- 发现直接销售道有效降低了药品价格.
- 增加零售商道力量会导致更高的零售价格和利,而增加制造商道力量会提高制造商的利,但会降低零售价格.
结论:
- 医疗保险退款率可以积极影响药品定价和整体供应链利能力.
- 道力量动态对制药供应链中的定价策略和利结果产生重大影响.
- 多道制药市场的竞争结构需要仔细考虑,以优化定价和利能力.
相关概念视频
Agonism and Antagonism: Quantification
254
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
254
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Biopharmaceutics and Pharmacokinetics: Overview
1.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.7K
Pharmacokinetic Models: Overview
493
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
493
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
76
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
76
Model Approaches for Pharmacokinetic Data: Compartment Models
51
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
51

